Edward Garon

33PUBLICATIONS
228CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Nov 06, 2026
PADL1NK-005 study design: a phase III trial of fetrastobart vedotin (Fetra-V) vs docetaxel in patients with previously treated tumor PD-L1-positive NSCLC.

|Nov 01, 2026
A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial.

|Sep 11, 2026
Lessons from Cohort Studies of Targetable Metabolic Deficiencies in Lung Cancer.

|Jul 22, 2026
Utilizing Machine Learning to Identify Multimodal Signatures for Patients Who Would Benefit from the Addition of Tremelimumab to Durvalumab and Chemotherapy (TRIDENT).

|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Apr 06, 2026
Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Weihua Zeng, Chun-Chi Liu, Shuo Li

Pageof 6

Frequent Collaborators

7 joint publications

Aaron Lisberg

7 joint publications

Shuo Li

6 joint publications

Amy L Cummings

6 joint publications

Xianghong Jasmine Zhou